Wrapped up the first edition of ERCA News, a monthly webinar on advanced CKD updates. Scientific and dynamic format, and great engagement. Proud to lead this initiative — and ready for the next season starting in September.

🎙️https://www.senefro.org/modules.php?name=noticias&d_op=view&idnew=1673

Honored to have participated in the 62nd ERA Congress in Vienna, both learning and contributing.

📍 Presented the IBERIK+ study on hyperkalemia in Spain

Always a privilege to be part of spaces that promote evidence, dialogue, and better care for our patients.

@theisn.org @sinnefro.bsky.social

Grateful to co-author two studies with the Microbiology Dept. at Hospital Clínico Valencia — a great example of how collaboration leads to better evidence and outcomes.
🦠🧪
📄 pubmed.ncbi.nlm.nih.gov/40326950/
📄 pubmed.ncbi.nlm.nih.gov/40232234/

@amersocvirology.bsky.social @senefrologia.bsky.social

💔➡️🧂🛑
Proud to have contributed to this review on tackling renal sodium avidity in chronic HF.
📊 Includes a clear infographic — open access: pubmed.ncbi.nlm.nih.gov/40228493/

@secardiologia.bsky.social @senefrologia.bsky.social @nefrontera.bsky.social @sinnefro.bsky.social

¡Llega el segundo ERCA News! Un proyecto formativo impulsado por los GdT de @senefrologia.bsky.social #ERCA y #senjoven.

Webinar 2⃣: 12 de mayo a las 17h (hora Madrid)
⏱️ En solo 30 minutos, comentamos 4-5 artículos clave sobre ERCA.
Inscripción gratuita aquí: us02web.zoom.us/webinar/regist…

⚠️ More common than cancer or diabetes
⚰️ Leading cause of premature death
💸 Huge cost: up to 4% of health budgets
❌ 98% lack access to dialysis in low-resource countries
♻️ Dialysis = high carbon footprint
🧠 Public awareness shockingly low

It's time to act.

nature.com/articles/s41581-024-00829-x

🔬 Multicenter study across Spain validates the KFRE equation in patients with advanced CKD. The 4-variable version shows strong predictive value for dialysis progression, though recalibration is needed. 📊 #nephrology #CKD #KFRE

doi.org/10.1016/j.nefro.2025.02.004

@senefrologia.bsky.social

Prouder of having involved the Nephrology Department at Hospital Clínico de Valencia in reviewing the latest topics than of the result itself… What a fun way to quickly go over current issues! 🚀 @senefrologia.bsky.social @theisn.org @ajkd.bsky.social @secardiologia.bsky.social

¡Ya puedes inscribirte al primer webinar de ERCA News! 📚
🗓️ Lunes 14/04 | 🕔 17:00h | 🎙️ Partecipo
Revisión de artículos clave sobre ERCA en 30 min.
Avalado por @senefrologia.bsky.social, con la colaboración de Vifor y @novonordisk.bsky.social
🔗 Inscríbete aquí: us02web.zoom.us/webinar/regi...

🩸 Kidney Oxygen Sensing 🏥
The kidneys regulate EPO based on oxygen levels. In #CKD, impaired sensing leads to anemia. 🏗️ Proximal tubule hypoxia plays a key role, while #HIF and #SGLT2i therapies may restore EPO production. #RenalPhysiology #Anemia

academic.oup.com/ndt/article/...

@theisn.org

🧠💊 Major progress in MN! While current therapies (rituximab, steroids) work for many, 20–30% face resistance. 🔬 New hope: anti-CD20 (obinutuzumab), anti-CD38 (daratumumab), anti-complement (iptacopan) & even CAR-T! The future is precision medicine. 🚀

academic.oup.com/ckj/article/...

#nephrology

A challenge and a test for nephrologists: optimizing the timing and sequencing of kidney protective therapies in CKD..

journals.lww.com/cjasn/fulltext…

aMR in the spectrum of cardiorenal diseases
💊 Spironolactone and eplerenone: For HFrEF or post-MI.
🩺 Finerenone: For CKD + T2D. Fewer hormonal side effects and stronger anti-inflammatory & anti-fibrotic effects.
⚠️ Consider renal function and risk of hyperkalemia.

academic.oup.com/ndt/article/...

🔬 New concept in nephrology: DMANDs (Disease-Modifying Anti-Nephropathic Drugs) are defined.

📌 Requirements:
✅ Reduce disease activity
✅ Prevent kidney damage
✅ Minimize toxicity

🚀 Goal: Improve treatments and avoid non-selective immunosuppressants.

academic.oup.com/ndt/advance-...